Orchard Therapeutics plc (NasdaqGS:ORTX) announced that it will receive $7.5 million in equity investment on July 1, 2021. The transaction will include participation from Pharming Group N.V. (ENXTAM:PHARM) and share will be issued at premium.
1st Jan change | Capi. | |
---|---|---|
+27.97% | 672B | |
+23.41% | 550B | |
-7.02% | 351B | |
+14.85% | 317B | |
+6.25% | 292B | |
+2.40% | 211B | |
-0.38% | 203B | |
-9.94% | 194B | |
-11.81% | 144B |